Diggnation (rebooted) cover image

Scoring a $400 Refund Thanks to AI | Diggnation

Diggnation (rebooted)

00:00

Kevin Rose's Biohacking and Ozempic

Summary: Kevin Rose shares his experience with Ozempic, a GLP-1 agonist, seven years before it became widely known, after a doctor suggested it based on his DEXA scan results showing high visceral fat. Rose used it for a month with positive results, lowering his visceral fat.

Insights:

  • DEXA scans can reveal not only bone density but also metrics like visceral fat and muscle mass, allowing for targeted health interventions.
  • Ozempic, now a popular drug, was relatively unknown seven years prior.
  • Visceral fat, surrounding organs, poses a significant health risk.

Proper Nouns:

  • Ozempic: A GLP-1 agonist used to treat type 2 diabetes and obesity.
  • DEXA scan: A type of scan used to measure bone density and body composition.
  • Tia: The doctor who suggested the GLP-1 agonist.
  • Colleen: A scientist developing a probiotic in an oxygen-free environment.

Research

  • What other benefits/drawbacks are associated with Ozempic?
  • How do GLP-1 agonists work to reduce visceral fat?
  • How accessible/accurate are at-home visceral fat measurement methods?
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app